Innovative Solutions for the Toughest Environmental Problems
​
We Make Life Better
About BioLargo
​
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over thirteen years of extensive R&D, BLGO holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BLGO has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets.
Corporate Presentation
BioLargo Companies and Technologies

President & CEO:
Dennis P. Calvert
BioLargo, Inc. (OTCQB:BLGO) supports four subsidiaries that develop and commercialize cleantech products and specialty services. BioLargo holds the intellectual property for each technology and product.

President:
Dr. Richard Smith
Flagship product:​
​
The Advanced Oxidation System (AOS):
-
Exceptional disinfection performance with concurrent decontamination
-
Ultra low energy consumption
-
Lower costs than competitors (OPEX and CAPEX)
-
Modular - Flexible - Scalable
​
Click HERE to learn more
BIOLARGO ENVIRONMENTAL GROUP
President:
Joseph Provenzano
Flagship product:​
​
CupriDyne Clean Industrial Odor and VOC Eliminator:
-
Eliminates odors; doesn't mask them
-
Non-toxic, non-sensitizing, non-fragranced
-
Effective against VOCs, ammonia, sulfur compounds, mercaptans, fatty acids
-
Misting systems: design, build, install, maintain, service options available
​
Click HERE to learn more
Minority Interest Medical Technologies Subsidiary:
President:
Steve Harrison
Clyra Advanced Wound Care Products:
-
Infection control, chronic wound therapy, regenerative tissue therapy
-
Non-cytotoxic, safe, broad-spectrum antimicrobial action. Efficacy proven.
-
No bacterial resistance.
-
Hydrogels, dressings, liquids
-
Clyraguard - personal protective spray for use on PPE. Hospital-grade, FDA registered.
-
First product FDA 510(k) approved
​
Click HERE to learn more
BioLargo Blog
BioLargo Corporate Deck
Want to learn more about BioLargo, Inc. and its subsidiaries? A great place to learn more is our corporate deck, which you can download by clicking the button below.
​
​
​
​
Please visit the company's SEC filings page (in "Investor Relations") for the most complete company information.